(Q48714778)

14 February 2018

review article

1 reference

title

A rational approach to managing stage I nonseminomatous germ cell cancer. (English)

1 reference

14 February 2018

author name string

Lashley DB

series ordinal

1

1 reference

14 February 2018

Lowe BA

series ordinal

2

1 reference

14 February 2018

publication date

1 August 1998

1 reference

14 February 2018

Urologic Clinics of North America

published in

1 reference

14 February 2018

volume

25

1 reference

14 February 2018

issue

3

1 reference

14 February 2018

page(s)

405-423

1 reference

14 February 2018

Late relapse of clinical stage I testicular cancer

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Cost- and risk-benefit considerations in the management of clinical stage I nonseminomatous testicular tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Postradical orchiectomy hemorrhage: should an alteration in staging strategy for testicular cancer be considered?

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Treatment of clinical stage I testicular cancer and a possible role for new biological prognostic parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Roentgenographic visualization of human testicular lymphatics: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Results of the surveillance policy of stage I non-seminomatous germ cell testicular tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Management preferences in stage I non-seminomatous germ cell tumours of the testis: an investigation among patients, controls and oncologists

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Nerve-sparing retroperitoneal lymphadenectomy for low stage testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Flow-cytometric and quantitative histologic parameters as prognostic indicators for occult retroperitoneal disease in clinical-stage-I non-seminomatous testicular germ-cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Nerve-sparing retroperitoneal lymphadenectomy with preservation of ejaculation

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Primary retroperitoneal lymph node dissection in clinical stage A non-seminomatous germ cell testis cancer. Review of the Indiana University experience 1965-1989.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Distribution of nodal metastases in nonseminomatous testis cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Comparison of NMR and CT imaging in the evaluation of metastatic retroperitoneal lymphadenopathy from testicular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

How safe is surveillance in patients with histologically low-risk non-seminomatous testicular cancer in a geographically extended country with limited computerised tomographic resources?

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

The fertility of patients with clinical stage I testis cancer managed by nerve sparing retroperitoneal lymph node dissection

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Surgical treatment of patients with stages I and II nonseminomatous testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Orchiectomy only for clinical stage I nonseminomatous germ cell testis tumors: comparison with pathologic stage I disease

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Laparoscopic retroperitoneal lymphadenectomy: multi-institutional analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Treatment of stage I testicular tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Treatment Decision for Stage I Non-seminomatous Germ Cell Tumours Based on the Risk Factor “Vascular Invasion”

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Prognostic factors in stage I non-seminomatous germ-cell testicular tumors managed by orchiectomy and surveillance: implications for adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Histopathological features in stage I non-seminomatous testicular germ cell tumours correlated to relapse. Danish Testicular Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Retroperitoneal lymphadenectomy for testis tumor with nerve sparing for ejaculation

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Gonadal dysfunction in patients treated for metastatic germ-cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Testis tumors; report on 250 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Flow cytometric and quantitative histological parameters to predict occult disease in clinical stage I nonseminomatous testicular germ cell tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Complications of therapy for testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Ejaculation and fertility after extended retroperitoneal lymph node dissection for testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Justification of the use of surveillance in the management of Stage I germ cell tumours of the testis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

1 reference

7 January 2021

Orchidectomy alone in testicular stage I non-seminomatous germ-cell tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

No Adjuvant Chemotherapy in Selected Patients with Pathologic Stage II Nonseminomatous Germ Cell Tumors of the Testis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Unilateral lymphadenectomy in intraoperative stage I nonseminomatous germinal testis cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Orchiectomy alone in clinical stage I nonseminomatous testis cancer: a critical appraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Difficulties of a surveillance study omitting retroperitoneal lymphadenectomy in clinical stage I nonseminomatous germ cell tumors of the testis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Risk-adapted treatment choice in stage I nonseminomatous testicular germ cell cancer by regarding vascular invasion in the primary tumor: a prospective trial

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Surveillance for stage I non-seminomatous germ cell tumours of the testis: the optimal protocol has not yet been defined

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Early detection of relapse after treatment for metastatic germ cell tumour of the testis: an exercise in medical audit.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Distribution of retroperitoneal lymph node metastases in testicular germinal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Clinical stage 1 testicular cancer: the role of modified retroperitoneal lymphadenectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Computerized tomography: how accurate for abdominal staging of testis tumors?

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Is adjuvant chemotherapy necessary for patients with stage B1 testicular cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Orchidectomy alone versus orchidectomy plus radiotherapy in stage I nonseminomatous testicular cancer: a randomized study by the Danish Testicular Carcinoma Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Complications of retroperitoneal lymphadenectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Accuracy of radiological staging procedures in non-seminomatous testis cancer compared with findings from surgical exploration and histopathological studies of extirpated tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Sexual and marital counseling with men treated for testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Chest staging in testis cancer patients: imaging modality selection based upon risk assessment as determined by abdominal computerized tomography scan results

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Complications of thoracoabdominal retroperitoneal lymph node dissection

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Surveillance versus adjuvant chemotherapy in stage I non-seminomatous testicular cancer: a decision analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Adjuvant chemotherapy after orchiectomy in high-risk patients with clinical stage I non-seminomatous testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Surveillance after orchidectomy for patients with clinical stage I nonseminomatous testis tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Low stage testis cancer is still potentially lethal

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Lymphangiography and computerized tomography in testicular carcinoma: how accurate in early stage disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Staging of testicular carcinoma: comparison of CT and lymphangiography

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

An analysis of surveillance for stage I combined teratoma--seminoma of the testis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Disease relapse in patients with stage I nonseminomatous germ cell tumor of the testis on active surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Identifying patients with low-risk clinical stage I nonseminomatous testicular tumors who should be treated by surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Are lymphangiograms necessary before placing patients with nonseminomatous testicular tumors on surveillance?

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

Compliance with follow-up of patients treated for non-seminomatous testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970031-8

7 January 2021

10.1016/S0094-0143(05)70031-8

Identifiers

DOI

1 reference

14 February 2018

PubMed ID

9728211

1 reference

14 February 2018